Center for Predictive Medicine and Emerging Infectious Diseases Expands Biosafety Lab, Purchases Provantis SaaS
NIH Grant Helps University of Louisville Expand Facilities and Research Program Capabilities
CONSHOHOCKEN, PA - (BUSINESS WIRE) – October 22, 2014 - -Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that The University of Louisville (UofL) Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases (CPM) has purchased their Provantis® preclinical software solution as part of an expansion program.
UofL funding for the expansion of its facilities and the purchase of Provantis were awarded through a National Institutes of Health (NIH) initiative to improve the nation’s top research facilities.
Provantis will be used within the Regional Biocontainment Laboratory (RBL), a state-of-the-art facility providing scientific expertise and biosafety level three (BSL-3) laboratories for the discovery of therapeutics for serious pathogens, and an infrastructure to meet pandemic or bioterrorism emergency needs. The RBL, one of 11 in the country, serves as a valuable shared resource to others in academic, not-for-profit and private sectors for BSL-3 training, basic research and translational discovery efforts.
Instem’s Provantis preclinical software will replace manual paper-based processes with an integrated and automated approach to long term efficacy/product evaluation studies. Researchers will more easily collect and share critical data with the NIH in their efforts to develop vaccines aimed at fighting bioterrorism and emerging infectious diseases.
CPM at UofL will be using Instem’s SaaS (Software-as-a-Service) model to access Provantis offering simpler, more cost effective ways to provide software functionality, maintenance, and support over the Internet. Instem’s professionally managed cloud platforms are run from a centralized state-of-the-art data center, which is being used by clients running GLP and non-GLP studies around the world.
- University of Louisville Center for Predictive Medicine and Infectious Diseases purchases Provantis General Toxicology and Pathology modules
- University of Louisville Center for Predictive Medicine and Infectious Diseases using Instem’s SaaS delivery model
- Provantis being deployed in biosafety level three laboratories at Regional Biocontainment Facility
- Provantis replacing paper-based processes, streamlining workflows within research center and with NIH
About the CPM at UofL
The mission of the CPM at the University of Louisville is to improve human health by conducting basic and translational research that leads to the development of effective diagnostic biomarkers, vaccines, antivirals and therapeutics for emerging, re-emerging, neglected or rare infectious diseases.
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.
Instem’s portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.
Instem supports over 400 clients through full service offices in the United States, United Kingdom and China with additional locations in India and a full service distributor based in Japan.
Meeting clients at the intersection of investment & return™.
Gary Mitchell (US HQ)
Julie Jones (UK HQ)
Tel: +44 (0) 1785 825600